Advanced Viral Research CP (ADVR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Advanced Viral Research CP (ADVR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: garden_man who wrote (2049)	1/15/1997 10:54:00 PM
From: s martin	of 2281

Shawn, I see you got another non answer to the issues. Joes' explanation of "r" is ridiculous. If ADVR should happen to get good management, and all the tests were to show "r" worked, very doubtful, AND the FDA appproved its use, you still don't have anything but air because it isn't and cannot be patented. In the unlikely event that Reticulous is proved to work, it would be copied quickly by viable companies and ADVR is left sucking wind. They have what they call "exclusive rights" to the product. But their "exclusive rights" aren't worth the paper it takes to print them on. So, could one of you long term investors tell us how it could become a profitable company? To get to FDA approval takes on average 3 years and $12,000,000. What is the return on investment if you don't have a patent and can't get one? Shawn, could you give more information on the Fishbacks who are they? And what role do they play in all of this?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next